Doxycycline Capsules — Class II drug recall D-1032-2020
Terminated recall by Sun Pharmaceutical Industries, Inc., reported 2020-03-25, distributed nationwide. CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditio
| Recall number | D-1032-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sun Pharmaceutical Industries, Inc., Cranbury, NJ, United States |
| Recall initiated | 2020-03-13 |
| Classified | 2020-03-18 |
| Reported by FDA | 2020-03-25 |
| Terminated | 2021-02-09 |
| Distributed | Nationwide (US) |
| Quantity | 624 bottles |
| Reason classes | cgmp |
| NDC | 63304-0614, 63304-0614-01, 63304-0614-05, 63304-0614-13, 63304-0614-20, 63304-0615, 63304-0615-01, 63304-0615-05, 63304-0615-11, 63304-0616, 63304-0616-01, 63304-0616-05, 63304-0616-13, 63304-0616-20, 63304-0616-50 |
| Lot numbers | AA39490 |
| Expiration dates | 2021-03 |
Product
Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.
Reason for recall
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1032-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.